Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.
Saved in:
| Title: | Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy. |
|---|---|
| Authors: | Laloi, Louise1 (AUTHOR), Billotey, Natacha Chaumard1 (AUTHOR), Dumas, Pierre‐Yves2 (AUTHOR), Paul, Franciane3 (AUTHOR), Villate, Alban4 (AUTHOR), Simand, Célestine5 (AUTHOR), Fornecker, Luc5 (AUTHOR), Puisset, Florent6 (AUTHOR), Bertoli, Sarah7 (AUTHOR), Simonet, Marion Boissard8 (AUTHOR), Laribi, Kamel9 (AUTHOR), Houyou, Dyhia10 (AUTHOR), Santagostino, Alberto11 (AUTHOR), Michel, Claire12 (AUTHOR), Guepin, Gabrielle Roth12 (AUTHOR), Guerineau, Elodie13 (AUTHOR), Tabrizi, Reza14 (AUTHOR), Hunault, Mathilde15 (AUTHOR), Giltat, Aurélien15 (AUTHOR), Kaphan, Eléonore16 (AUTHOR) |
| Source: | Cancer Medicine. Mar2023, Vol. 12 Issue 6, p7175-7181. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
